ATE425962T1 - Peptid-deformylase-hemmer - Google Patents

Peptid-deformylase-hemmer

Info

Publication number
ATE425962T1
ATE425962T1 AT03719773T AT03719773T ATE425962T1 AT E425962 T1 ATE425962 T1 AT E425962T1 AT 03719773 T AT03719773 T AT 03719773T AT 03719773 T AT03719773 T AT 03719773T AT E425962 T1 ATE425962 T1 AT E425962T1
Authority
AT
Austria
Prior art keywords
peptide deformylase
deformylase inhibitors
inhibitors
peptide
novel
Prior art date
Application number
AT03719773T
Other languages
English (en)
Inventor
Siegfried Christensen
Maxwell CUMMINGS
Jinhwa Lee
Jia-Ning Xiang
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE425962T1 publication Critical patent/ATE425962T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
AT03719773T 2003-04-16 2003-04-16 Peptid-deformylase-hemmer ATE425962T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/011704 WO2004098584A1 (en) 2003-04-16 2003-04-16 Peptide deformylase inhibitors

Publications (1)

Publication Number Publication Date
ATE425962T1 true ATE425962T1 (de) 2009-04-15

Family

ID=33434321

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03719773T ATE425962T1 (de) 2003-04-16 2003-04-16 Peptid-deformylase-hemmer

Country Status (8)

Country Link
US (1) US7375120B2 (de)
EP (1) EP1615629B1 (de)
JP (1) JP4373343B2 (de)
AT (1) ATE425962T1 (de)
AU (1) AU2003223634A1 (de)
DE (1) DE60326773D1 (de)
ES (1) ES2322451T3 (de)
WO (1) WO2004098584A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MX2007014613A (es) 2005-05-20 2008-04-02 Johnson & Johnson Procedimiento para la preparacion de derivados de sulfamida.
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
AR058389A1 (es) 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
WO2007137167A2 (en) 2006-05-19 2007-11-29 Janssen Pharmaceutica N.V. Co-therapy for the treatment of epilepsy
AU2009271362B2 (en) 2008-06-23 2014-03-13 Janssen Pharmaceutica Nv Crystalline form of (2s)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985900A (en) * 1997-04-01 1999-11-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
JP2002322197A (ja) * 2001-04-24 2002-11-08 Senju Pharmaceut Co Ltd ペプチジルヒドロキサム酸誘導体およびその用途
ATE448198T1 (de) * 2002-07-22 2009-11-15 Senju Pharma Co Neue alpha-ketoamidderivate und deren verwendung

Also Published As

Publication number Publication date
EP1615629A1 (de) 2006-01-18
AU2003223634A1 (en) 2004-11-26
ES2322451T3 (es) 2009-06-22
WO2004098584A1 (en) 2004-11-18
US20060229341A1 (en) 2006-10-12
US7375120B2 (en) 2008-05-20
EP1615629B1 (de) 2009-03-18
JP2006523612A (ja) 2006-10-19
JP4373343B2 (ja) 2009-11-25
EP1615629A4 (de) 2007-02-28
DE60326773D1 (de) 2009-04-30

Similar Documents

Publication Publication Date Title
NO20054453L (no) P38 inhibitorer og fremgangsmater for anvendelse derav
DK1606283T3 (da) P38-inhibitorer og fremgangsmåder til anvendelse deraf
MY133625A (en) Peptide deformylase inhibitors
UY27192A1 (es) Inhibidores de peptido-deformilasa
ATE425962T1 (de) Peptid-deformylase-hemmer
NO20025281L (no) Peptid-deformylase-inhibitorer
ATE548037T1 (de) Peptid-deformylase-hemmer
WO2004052919A3 (en) Peptide deformylase inhibitors
ATE312077T1 (de) Peptiddeformylase-hemmer
NO20053071L (no) Kalsilytiske forbindelser.
ATE514683T1 (de) Peptid-deformylase-hemmer
WO2005005456A3 (en) Peptide deformylase inhibitors
ATE309984T1 (de) Peptid-deformylase-hemmer
ATE433953T1 (de) Peptiddeformylaseinhibitoren
ATE531690T1 (de) Inhibitoren von peptiddeformylase
WO2007016364A3 (en) Peptide deformylase inhibitors
WO2002070653A3 (en) Peptide deformylase inhibitors
WO2005017124A3 (en) Peptide deformylase inhibitors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties